TORNIAI, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 2.338
EU - Europa 909
AS - Asia 853
SA - Sud America 138
AF - Africa 78
OC - Oceania 1
Totale 4.317
Nazione #
US - Stati Uniti d'America 2.306
SG - Singapore 303
IT - Italia 163
CN - Cina 161
VN - Vietnam 157
RU - Federazione Russa 153
BR - Brasile 111
DE - Germania 99
UA - Ucraina 91
IE - Irlanda 80
SE - Svezia 75
FI - Finlandia 64
HK - Hong Kong 64
FR - Francia 53
TR - Turchia 52
CI - Costa d'Avorio 42
GB - Regno Unito 39
IN - India 29
DK - Danimarca 26
BD - Bangladesh 21
CA - Canada 21
KR - Corea 16
MA - Marocco 15
BE - Belgio 14
PL - Polonia 14
AR - Argentina 12
JP - Giappone 12
NL - Olanda 12
ZA - Sudafrica 11
ES - Italia 9
IQ - Iraq 6
MX - Messico 6
LT - Lituania 5
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
EC - Ecuador 3
ID - Indonesia 3
KE - Kenya 3
PH - Filippine 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
CY - Cipro 1
DZ - Algeria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.317
Città #
Ashburn 440
Singapore 223
Chandler 218
Fairfield 139
Jacksonville 131
Des Moines 113
San Jose 103
New York 82
Dublin 80
Wilmington 74
Boardman 68
Hong Kong 63
Woodbridge 58
Seattle 56
Los Angeles 55
Houston 54
Ho Chi Minh City 50
Cambridge 49
Beijing 47
Dallas 44
Abidjan 42
The Dalles 38
Ann Arbor 37
Munich 36
Hanoi 33
Turku 32
Lawrence 31
Princeton 31
Turin 31
San Mateo 30
Lauterbourg 28
Moscow 28
Helsinki 18
Orem 18
Washington 16
Milan 15
Brussels 14
Chicago 14
San Diego 14
Warsaw 14
Buffalo 13
Santa Clara 13
São Paulo 13
Chennai 12
Frankfurt am Main 12
Montreal 11
Centro 10
Columbus 10
Hefei 10
London 10
Tokyo 10
Da Nang 9
Falls Church 9
Haiphong 9
Pune 9
Council Bluffs 8
Shanghai 8
Brooklyn 7
Hải Dương 7
Johannesburg 7
Norwalk 7
Amsterdam 6
Ancona 6
Denver 6
Guangzhou 6
Kilburn 6
Miano 6
Phoenix 6
Poplar 6
Ankara 5
Paris 5
Rome 5
Atlanta 4
Guarulhos 4
Istanbul 4
Manchester 4
Rio de Janeiro 4
Urbisaglia 4
Baghdad 3
Baku 3
Charlotte 3
City of London 3
Cleveland 3
Jiaxing 3
Montegiorgio 3
Mumbai 3
Nairobi 3
Pittsburgh 3
Quito 3
Salt Lake City 3
Salvador 3
Wuxi 3
Điện Bàn 3
Ấp Tháp Mười 3
Anápolis 2
Boston 2
Bến Tre 2
Campos dos Goytacazes 2
Casablanca 2
Castelraimondo 2
Totale 3.018
Nome #
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 198
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 192
Gender Differences and Outcomes in Melanoma Patients 163
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 161
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 160
Electrolyte disorders in cancer patients: a systematic review 160
Benefits and limitations of a multidisciplinary approach in cancer patient management 153
High CTLA-4 expression correlates with poor prognosis in thymoma patients 149
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 148
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 145
Systemic treatment for lung carcinoids: from bench to bedside 145
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 145
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 142
Gender differences and outcome of melanoma patients 142
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 141
Hyponatremia in cancer patients: Time for a new approach 140
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 139
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 138
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 134
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 132
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 131
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 128
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 127
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 124
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 123
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 120
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 118
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 116
Medical Treatment in Gastroenteropancreatic Neuroendocrine Neoplasms: a look into the future. 114
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study 106
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 101
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 49
Totale 4.384
Categoria #
all - tutte 20.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022246 16 36 14 3 7 30 11 12 28 24 25 40
2022/2023666 40 78 42 58 30 165 0 35 128 4 70 16
2023/2024360 51 6 31 22 48 107 7 25 1 15 1 46
2024/2025589 71 53 17 4 41 31 52 25 103 27 78 87
2025/20261.670 153 77 54 190 206 131 300 158 127 165 47 62
Totale 4.384